22-03-04 Oxford Technology Vct Plc, Oxford Technology 3 Vct Plc, Oxford Technology 4 Vct plc Plans to Change Accounting Reference Date to August 31 CI
21-06-29 Oxford Technology Venture Capital Trust plc Reports Earnings Results for the Full Year Ended February 28, 2021 CI
20-10-09 Oxford Technology Venture Capital Trust plc Reports Earnings Results for the Half Year Ended August 31, 2020 CI
20-07-08 Oxford Technology Venture Capital Trust plc Declares Interim Dividend, Payable on July 31, 2020 CI
20-05-20 Oxford Technology Venture Capital Trust plc Reports Earnings Results for the Full Year Ended February 29, 2020 CI
19-05-22 Oxford Technology Venture Capital Trust plc Reports Audited Earnings Results for the Year Ended February 28, 2019 CI
18-10-24 Oxford Technology Venture Capital Trust plc Reports Unaudited Earnings Results for the Six Months Ended August 31, 2018 CI
18-05-03 Oxford Technology Venture Capital Trust plc Not to Pay Dividend for the Year Ended 28 February 2018 CI
18-05-03 Oxford Technology VCT plc Announces Audited Earnings Results for the Year Ended February 28, 2018 CI
17-10-23 Oxford Technology VCT plc Announces Unaudited Earnings Results for the Half Year Ended August 31, 2017 CI
17-07-06 Oxford Technology Venture Capital Trust plc Proposes Final Dividend, Payable on July 21, 2017 CI
17-05-10 Oxford Technology VCT plc Recommends Final Revenue Dividend, Payable on July 21, 2017 CI
17-05-10 Oxford Technology VCT plc Announces Earnings Results for the Year Ended February 28, 2017 CI
Logo OXFORD TECHNOLOGY VCT
Oxford Technology Venture Capital Trust Plc is a United Kingdom-based venture capital trust (VCT). The Company focuses on investing in early stage and start-up technology companies. It has holdings in four companies, namely Arecor Therapeutics Plc (Arecor), BioCote Ltd (BioCote), Getmapping Plc, Scancell Holdings Plc (Scancell) and STL Management Limited (Select Technology). The Company's subsidiary OT1 Managers Ltd helps to provides investment management services to the Company. Arecor is a biopharmaceutical company that focuses on delivering enhanced reformulations of its partner's therapeutic products. BioCote is engaged in supplying the material, formulated for the needs of each customer, and the coating is then applied in the customers' factories, which is anti-microbial. Scancell is focused on developing immunotherapies for cancer that stimulate the body's own immune system. Select Technology specializes in software for photocopiers known as Multi-Function Devices (MFDs).
Employees
36
Sector
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!